Watson Conall H, Edmunds W John
Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, United Kingdom.
Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, United Kingdom.
Vaccine. 2015 Jun 19;33 Suppl 3(Suppl 3):C42-54. doi: 10.1016/j.vaccine.2015.04.013. Epub 2015 Apr 25.
Despite a recommendation by the World Health Organization (WHO) that typhoid vaccines be considered for the control of endemic disease and outbreaks, programmatic use remains limited. Transmission models and economic evaluation may be informative in decision making about vaccine programme introductions and their role alongside other control measures. A literature search found few typhoid transmission models or economic evaluations relative to analyses of other infectious diseases of similar or lower health burden. Modelling suggests vaccines alone are unlikely to eliminate endemic disease in the short to medium term without measures to reduce transmission from asymptomatic carriage. The single identified data-fitted transmission model of typhoid vaccination suggests vaccines can reduce disease burden substantially when introduced programmatically but that indirect protection depends on the relative contribution of carriage to transmission in a given setting. This is an important source of epidemiological uncertainty, alongside the extent and nature of natural immunity. Economic evaluations suggest that typhoid vaccination can be cost-saving to health services if incidence is extremely high and cost-effective in other high-incidence situations, when compared to WHO norms. Targeting vaccination to the highest incidence age-groups is likely to improve cost-effectiveness substantially. Economic perspective and vaccine costs substantially affect estimates, with disease incidence, case-fatality rates, and vaccine efficacy over time also important determinants of cost-effectiveness and sources of uncertainty. Static economic models may under-estimate benefits of typhoid vaccination by omitting indirect protection. Typhoid fever transmission models currently require per-setting epidemiological parameterisation to inform their use in economic evaluation, which may limit their generalisability. We found no economic evaluation based on transmission dynamic modelling, and no economic evaluation of typhoid vaccination against interventions such as improvements in sanitation or hygiene.
尽管世界卫生组织(WHO)建议考虑使用伤寒疫苗来控制地方病和疫情,但在实际项目中的使用仍然有限。传播模型和经济评估可能有助于就疫苗项目的引入及其与其他控制措施协同发挥的作用做出决策。文献检索发现,相对于对其他健康负担相似或更低的传染病的分析而言,伤寒传播模型和经济评估较少。建模表明,在没有减少无症状携带者传播措施的情况下,仅靠疫苗在短期至中期内不太可能消除地方病。唯一确定的伤寒疫苗接种数据拟合传播模型表明,以项目方式引入疫苗时可大幅减轻疾病负担,但间接保护取决于特定环境中携带者对传播的相对贡献。这是流行病学不确定性的一个重要来源,自然免疫的程度和性质也是如此。经济评估表明,如果发病率极高,伤寒疫苗接种对卫生服务而言可能节省成本,与WHO标准相比,在其他高发病率情况下具有成本效益。将疫苗接种目标对准发病率最高的年龄组可能会大幅提高成本效益。经济视角和疫苗成本对估计有重大影响,疾病发病率、病死率以及疫苗随时间的效力也是成本效益的重要决定因素和不确定性来源。静态经济模型可能会因忽略间接保护而低估伤寒疫苗接种的益处。目前,伤寒热传播模型需要针对具体环境进行流行病学参数化,以便为其在经济评估中的应用提供依据,这可能会限制其通用性。我们未发现基于传播动态建模的经济评估,也未发现针对伤寒疫苗接种与改善卫生设施或卫生条件等干预措施进行的经济评估。